Live Oak Workshops, in collaboration with Sidley Austin, are designed to equip you with the knowledge and critical thinking strategies that lead to success in the advancement of your GXP […]

Deal and investment activity remains critical to the success of life sciences and healthcare innovation. RSVP Here Sidley once again brings together senior pharma, biotech, healthcare, private equity, and venture […]

Join us in Basel for our next Women’s Life Sciences Network event. The panel will discuss key considerations related to authority expectations as well as challenges, and potential strategies for […]

Join us in Basel, where Sidley and thought leaders will be discussing the FDA and Swissmedic Mutual Recognition Agreement on Good Manufacturing Practices for pharmaceutical products. This agreement aims to […]

Please join Sidley’s Global Life Sciences team to lean into key early-stage and emerging growth regulatory issues, and how to tackle them. If have questions or are interested in attending, […]

Join Sidley’s Life Sciences team for an afternoon of thought-provoking and engaging discussions touching on the latest trends and hot topics including the new administration, new technologies, the investment landscape, […]

Join us in Brussels for our next Women’s Life Sciences Network event on the occasion of the EU Pharmaceutical Law Forum. The event will feature a moderated discussion with Rainer Becker, Director, DG SANTE, European Commission, on topical issues of pharmaceutical legislation and policy. Stay tuned for a formal invitation and additional speaker announcements coming soon.

The Swiss MedTech industry stands at a critical crossroads: navigating rapid regulatory evolution, geopolitical shifts, and emerging technologies. RSVP here. For more information, please contact Geneva Events. Join us in Bern for […]

With deal and investment activity remaining critical to the success of the life sciences and healthcare industry, Sidley is bringing together senior pharma, biotech, healthcare, private equity, and venture capital […]